Want to see IN:PLATIND full AI Analyst Report?
PLATIND Stock Chart & Stats
₹245.55
-₹5.40(-1.29%)
At close: 4:00 PM EST
₹245.55
-₹5.40(-1.29%)
Day’s Range― - ―
52-Week Range₹183.60 - ₹341.90
Previous CloseN/A
Volume210.67K
Average Volume (3M)45.87K
Market Cap
₹12.58B
Enterprise Value₹11.81B
Total Cash (Recent Filing)₹1.43B
Total Debt (Recent Filing)₹104.34M
Price to Earnings (P/E)24.2
Beta1.23
Next Earnings
Aug 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)9.47
Shares Outstanding54,924,873
10 Day Avg. Volume8,384
30 Day Avg. Volume45,866
Financial Highlights & Ratios
PEG Ratio4.55
Price to Book (P/B)2.30
Price to Sales (P/S)2.26
P/FCF Ratio-31.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low debt-to-equity provides durable financial flexibility: the firm can fund capex or cushion working-capital swings without pressuring interest coverage. This conservative structure reduces refinancing risk and supports resilience through industry cycles.
Revenue Scaling With ProfitabilitySustained top-line growth alongside a mid-teens-level net margin shows the business can expand sales while retaining profitability. That revenue momentum supports market positioning, economies of scale and long-term reinvestment to deepen competitive strengths.
Healthy ROE And Growing Equity BaseROE in the low-teens combined with an expanding equity base indicates the company is generating respectable returns while de-risking its capital structure. This mix supports sustainable shareholder value creation and eases pressure to rely on external leverage.
Bears Say
Persistently Negative Free Cash FlowConsecutive large negative free cash flows imply heavy reinvestment or working-capital strain that is not converting to free liquidity. Over months this elevates dependence on external funding or equity, which can dilute returns and constrain strategic optionality if unresolved.
Meaningful Margin CompressionA rapid multi-year decline in gross margin signals structural pressure—higher input costs, pricing weakness or adverse mix—that can permanently reduce operating cash flow and ROI. If margins don't recover, growth will translate into lower profitability and weaker capital returns.
Weak Cash ConversionLow operating cash flow versus reported earnings highlights weak cash conversion, reducing the company's ability to self-fund growth and service investments. This structural inefficiency increases reliance on balance-sheet liquidity and raises vulnerability to working-capital shocks.
Platinum Industries Limited News
PLATIND FAQ
What was Platinum Industries Limited’s price range in the past 12 months?
Platinum Industries Limited lowest stock price was ₹183.60 and its highest was ₹341.90 in the past 12 months.
What is Platinum Industries Limited’s market cap?
Platinum Industries Limited’s market cap is ₹12.58B.
When is Platinum Industries Limited’s upcoming earnings report date?
Platinum Industries Limited’s upcoming earnings report date is Aug 19, 2026 which is in 31 days.
How were Platinum Industries Limited’s earnings last quarter?
Platinum Industries Limited released its earnings results on May 12, 2026. The company reported ₹2.75 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.75.
Is Platinum Industries Limited overvalued?
According to Wall Street analysts Platinum Industries Limited’s price is currently Overvalued.
Does Platinum Industries Limited pay dividends?
Platinum Industries Limited does not currently pay dividends.
What is Platinum Industries Limited’s EPS estimate?
Platinum Industries Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Platinum Industries Limited have?
Platinum Industries Limited has 54,924,873 shares outstanding.
What happened to Platinum Industries Limited’s price movement after its last earnings report?
Platinum Industries Limited reported an EPS of ₹2.75 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.82%.
Which hedge fund is a major shareholder of Platinum Industries Limited?
Currently, no hedge funds are holding shares in IN:PLATIND
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Platinum Industries Limited
Platinum Industries Limited, established in 2016 and headquartered in Mumbai, India, specializes in the production and distribution of vital chemical components. The company supplies polyvinyl chloride (PVC) stabilizers, chlorinated polyvinyl chloride (CPVC) additives, and various lubricants to both the Indian domestic market and international clients. Its comprehensive product range features PVC stability solutions, including both traditional lead-based and hybrid stabilizers, alongside full PVC additive packages. Platinum Industries also offers environmentally conscious non-lead alternatives, such as calcium-zinc and organic stabilizers with their respective additive formulations. Furthermore, the company provides specialized CPVC compound additives and additive packages, as well as a variety of lubricants like polyethylene (PE) waxes and unique lubpacks. These essential ingredients are integral to the manufacturing of a broad spectrum of polymer-based products. Key applications include PVC pipes, profiles, and fittings; electrical wiring and cables; SPC floor tiles; durable rigid PVC foam boards; and diverse packaging materials.
Technical Analysis
AVT Natural Products Limited
―
Ester Industries Limited
―
IG Petrochemicals Ltd.
―
Oriental Aromatics Ltd.
―
Rossari Biotech Ltd
―






